Search

Filters

Clear Filters
4:00 PM - 4:05 PM ET

1142 - Efficacy of Ultra-high Dose Rate (Flash) Proton Therapy Concomitantly with LIFE Biomaterial in Murine Pancreatic Cancer Treatment
Speaker: Moreau, Michele, PhD - Johns Hopkins University, Baltimore, MD
4:05 PM - 4:10 PM ET

1143 - A Blood-based DNA Methylation Signature for Non-invasive Diagnosis and Prediction of Clinical Outcomes in Patients with Glioblastoma Enrolled on the Phase II Randomized VERTU Trial
Speaker: Vaios, Eugene, MD, MBA - Duke Cancer Institute, Durham, NC
4:10 PM - 4:15 PM ET

1144 - Targeting the CXCL16-Positive Macrophages Alleviates Radiation-Induced Pulmonary Fibrosis via Inhibiting Fibroblast Activation and Recruitment
Speaker: Liu, Yuanhui, MD - Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
5:20 PM - 5:25 PM ET

1145 - Improved Acute and Long-Term Patient-Reported Outcomes (PRO) after Accelerated Partial Breast Irradiation (APBI) vs. Whole Breast Irradiation (WBI) Post-Lumpectomy for Early-Stage Breast Cancer as Measured by Breast-Q<sup>TM</sup>
Speaker: Johnson, Nicholas, BS - University of Missouri - Kansas City, Kansas City, MO
5:25 PM - 5:30 PM ET

1146 - Adjuvant Endocrine Therapy Adherence and Outcomes in Early Breast Cancer Patients Treated With APBI: A Retrospective Analysis Stratified by LUMINA Criteria
Speaker: Wilson V, John, BS - University of South Florida, Tampa, FL
5:30 PM - 5:35 PM ET

1147 - Local Recurrence Risk in Patients with Microinvasive vs. Early-stage Invasive Breast Cancer: Long Term Outcomes from a Multi-institutional Series
Speaker: Gerber, Naamit, MD - NYU Langone Medical Center, Bronx, New York
5:35 PM - 5:40 PM ET

1148 - Validated Nomogram Tool Predicting Individualized Risks of Invasive Disease Recurrence for Breast Cancer Patients with N1mic Treated with and without Nodal Radiotherapy
Speaker: Naoum, George, MD, MS - Memorial Sloan Kettering Cancer Center, New York, NY
5:40 PM - 5:45 PM ET

1149 - Post-Mastectomy Radiotherapy in pT1-2N1 HER2-Enriched Breast Cancer: Reassessing Its Role in the Anti-HER2 Era
Speaker: Wang, Xiaofang, PhD - Fudan University Shanghai Cancer Center, Shanghai, Shanghai
3:00 PM - 3:10 PM ET

115 - International Pilot of an Immersive Virtual-Reality-Based Training in Intracavitary Cervical Cancer Brachytherapy Treatment: Educational Impact and Early Outcomes
Speaker: Peterson, John, MD - H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
5:45 PM - 5:50 PM ET

1150 - Dosimetric Predictors of Pneumonitis In Patients with Localized HER2-Positive Breast Cancer Receiving Radiotherapy and Trastuzumab-Emtansine
Speaker: Bacon, Hannah, MD, PhD - University of Toronto, Toronto, ON
5:20 PM - 5:25 PM ET

1151 - Dynamic Hematologic Trajectories and Machine Learning to Predict Survival and Radiotherapy Benefit In Unresectable Esophageal Squamous Cell Carcinoma Receiving Immunotherapy: A Multicenter, Real-World Study
Speaker: Zhao, Xiaohan, MD - Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei
5:25 PM - 5:30 PM ET

1152 - Community-Based Health System Validation of the SHIELD-RT Machine Learning Model to Prevent Acute Care Events During Radiotherapy
Speaker: Elia, Marianna, MS, BS - University of California San Francisco, San Francisco, CA